Written question asked by Llew Smith (Labour), in the House of Commons. It was due for an answer on Thursday, 20 March 1997. It was answered by Gerald Malone (Conservative) on Thursday, 20 March 1997 on behalf of the Department of Health.

Dept of Health

Question: On what dates the Medicines Control Agency first raised safety concerns regarding mumps, measles and rubella vaccines containing Urabe strain of mumps vaccine with the manufacturers of Pluserix-MMR and Immravax. - Inc ref to 265 c607-11W.

Answer: Mr. Smith: To ask the Secretary of State for Health on what dates the Medicines Control Agency first raised safety concerns regarding mumps, measles and rubella vaccines containing Urabe strain of mumps vaccine with the manufacturers of Pluserix-MMR and Immravac; and if he will make a statement. [21164] Mr. Malone: I refer the hon. Member to the replies given on 6 November 1995 at columns 607-11 which discuss the replacement of the Urabe strain of MMR vaccine with the current strain. Discussions between the Licensing Authority and marketing authorisation holder are confidential.

Secondary information